Cardiology Fiesta 2017
Avatar

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

By Cardiology Fiesta 2017 FEATURING Ralph DeFronzo
By Cardiology Fiesta 2017 FEATURING Ralph DeFronzo
9,560 views
November 10, 2017
Comments 7
Login to view comments. Click here to Login

Related Videos

64:45

Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

44.9K views
11:37

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

22.7K views
11:25

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

21.5K views
18:43

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

12.3K views
15:06

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

9.0K views
37:21

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

11.0K views
27:24

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

8.8K views
17:44

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

8.6K views
15:51

SGLT2 Inhibition in 2024: Use in Heart Failure and Mechanism of Acti…

28th Annual Heart Failure 2024: An Update on Therapy

M. Packer

99 views
61:49

Management of Heart Failure

Obafemi Awolowo University

O. A. Akinyele

547 views
19:30

Hot Topics in Heart Failure ACC.22

ACC 2022 Conference Coverage

N. Ibrahim

3.5K views
49:07

State-of-the-Art, Treatment of Diabetic Kidney Disease (DKD)

Primary Care Education Consortium

S. Brunton

248 views
10:02

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…

Emory Diabetes Education Training Academy

G. Umpierrez

3.8K views
27:52

Medical Management of Diastolic Dysfunction: Does The Emperor Finall…

Top Ten Topics in Clinical Cardiology 2023

S. Pinney

3.2K views
34:32

Important Safety Information - Off-Target Effects of New Therapies f…

Ronald Goldenberg

3.2K views
13:42

Current Status of Prevention and Treatment of Diabetic Nephropathy

George Bakris

3.4K views
34:04

Use of Finerenone in Patients with Diabetes Who Have Kidney Disease

The Texas Heart Institute

G. Bakris

2.3K views
13:43

What's the Ideal Therapy for Obesity?

Stanford Medicine

A. Yeoh

3.7K views
18:35

New

HFrEF: Essentials of Guideline Directed Medical Therapy Initiation a…

Cleveland Clinic Heart, Vascular and Thoracic Institute

A. Vest

101 views
30:08

Patients in Cardiometabolic Jeopardy: Evolving Strategies for Cardio…

MUSC Cardiology

D. Lloyd-Jones

102 views
AUTOPLAY